NBIX logo

Neurocrine Biosciences (NBIX) Current assets

annual current assets:

$1.72B+$117.70M(+7.32%)
December 31, 2024

Summary

  • As of today (May 29, 2025), NBIX annual total current assets is $1.72 billion, with the most recent change of +$117.70 million (+7.32%) on December 31, 2024.
  • During the last 3 years, NBIX annual current assets has risen by +$751.90 million (+77.29%).
  • NBIX annual current assets is now at all-time high.

Performance

NBIX Current assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXbalance sheet metrics

quarterly current assets:

$1.64B-$86.80M(-5.03%)
March 31, 2025

Summary

  • As of today (May 29, 2025), NBIX quarterly total current assets is $1.64 billion, with the most recent change of -$86.80 million (-5.03%) on March 31, 2025.
  • Over the past year, NBIX quarterly current assets has dropped by -$161.10 million (-8.95%).
  • NBIX quarterly current assets is now -12.72% below its all-time high of $1.88 billion, reached on September 30, 2024.

Performance

NBIX quarterly current assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXbalance sheet metrics

Current assets Formula

Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets

NBIX Current assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+7.3%-8.9%
3 y3 years+77.3%+60.9%
5 y5 years+107.5%+69.2%

NBIX Current assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+77.3%-12.7%+60.9%
5 y5-yearat high+107.5%-12.7%+69.2%
alltimeall timeat high+3013.9%-12.7%+6753.1%

NBIX Current assets History

DateAnnualQuarterly
Mar 2025
-
$1.64B(-5.0%)
Dec 2024
$1.99B(+21.3%)
$1.72B(-8.1%)
Sep 2024
-
$1.88B(+12.4%)
Jun 2024
-
$1.67B(-7.2%)
Mar 2024
-
$1.80B(+11.9%)
Dec 2023
$1.64B(+79.7%)
$1.61B(-2.6%)
Sep 2023
-
$1.65B(+10.2%)
Jun 2023
-
$1.50B(+4.5%)
Mar 2023
-
$1.43B(-1.4%)
Dec 2022
$915.20M(-16.8%)
$1.45B(+20.6%)
Sep 2022
-
$1.21B(+18.3%)
Jun 2022
-
$1.02B(+0.1%)
Mar 2022
-
$1.02B(+4.7%)
Dec 2021
$1.10B(+53.1%)
$972.80M(-3.3%)
Sep 2021
-
$1.01B(-9.4%)
Jun 2021
-
$1.11B(+2.3%)
Mar 2021
-
$1.09B(+6.8%)
Dec 2020
$718.50M(+51.3%)
$1.02B(-12.2%)
Sep 2020
-
$1.16B(+0.9%)
Jun 2020
-
$1.15B(+18.4%)
Mar 2020
-
$968.20M(+16.5%)
Dec 2019
$475.00M(+86.0%)
$831.00M(+1.4%)
Sep 2019
-
$819.23M(+9.4%)
Jun 2019
-
$748.81M(+18.3%)
Mar 2019
-
$633.19M(-14.2%)
Dec 2018
$255.37M(-2.8%)
$737.78M(+3.3%)
Sep 2018
-
$714.39M(+25.8%)
Jun 2018
-
$567.68M(+10.5%)
Mar 2018
-
$513.72M(-7.4%)
Dec 2017
$262.67M(+380.7%)
$554.92M(+1.2%)
Sep 2017
-
$548.49M(+2.2%)
Jun 2017
-
$536.75M(+124.2%)
Mar 2017
-
$239.45M(-22.9%)
Dec 2016
$54.64M(-39.8%)
$310.44M(-13.3%)
Sep 2016
-
$357.89M(-8.7%)
Jun 2016
-
$391.97M(-2.2%)
Mar 2016
-
$400.98M(+4.4%)
Dec 2015
$90.71M(+102.3%)
$384.07M(+0.3%)
Sep 2015
-
$382.79M(-1.7%)
Jun 2015
-
$389.42M(-3.8%)
Mar 2015
-
$404.95M(+104.3%)
Dec 2014
$44.83M(+621.4%)
$198.20M(+7.8%)
Sep 2014
-
$183.87M(-6.9%)
Jun 2014
-
$197.57M(-10.9%)
Mar 2014
-
$221.74M(+49.4%)
Dec 2013
$6.21M(-7.5%)
$148.46M(-6.8%)
Sep 2013
-
$159.22M(+2.2%)
Jun 2013
-
$155.85M(-2.8%)
Mar 2013
-
$160.40M(-15.3%)
Dec 2012
$6.71M(+14.0%)
$189.26M(+6.3%)
Sep 2012
-
$178.02M(-1.8%)
Jun 2012
-
$181.26M(-2.0%)
Mar 2012
-
$184.97M(+39.6%)
Dec 2011
$5.89M(-48.2%)
$132.48M(-2.7%)
Sep 2011
-
$136.13M(+13.4%)
Jun 2011
-
$120.04M(-5.2%)
Mar 2011
-
$126.58M(-4.9%)
Dec 2010
$11.37M
$133.05M(+1.1%)
DateAnnualQuarterly
Sep 2010
-
$131.59M(-8.5%)
Jun 2010
-
$143.76M(+110.4%)
Mar 2010
-
$68.33M(+23.4%)
Dec 2009
$15.43M(-58.0%)
$55.39M(-4.8%)
Sep 2009
-
$58.19M(+8.2%)
Jun 2009
-
$53.78M(-20.0%)
Mar 2009
-
$67.20M(-17.5%)
Dec 2008
$36.76M(-60.8%)
$81.42M(-17.6%)
Sep 2008
-
$98.81M(-13.0%)
Jun 2008
-
$113.63M(-25.3%)
Mar 2008
-
$152.20M(-16.8%)
Dec 2007
$93.71M(-52.2%)
$182.95M(+42.7%)
Sep 2007
-
$128.18M(-14.9%)
Jun 2007
-
$150.59M(-11.6%)
Mar 2007
-
$170.31M(-12.1%)
Dec 2006
$196.02M(-3.8%)
$193.66M(-5.4%)
Sep 2006
-
$204.78M(-14.9%)
Jun 2006
-
$240.63M(-12.4%)
Mar 2006
-
$274.72M(-1.6%)
Dec 2005
$203.81M(-0.8%)
$279.31M(-6.2%)
Sep 2005
-
$297.63M(+9.6%)
Jun 2005
-
$271.52M(-3.4%)
Mar 2005
-
$281.03M(-10.4%)
Dec 2004
$205.40M(+147.0%)
$313.81M(-6.8%)
Sep 2004
-
$336.66M(+0.2%)
Jun 2004
-
$336.05M(-11.9%)
Mar 2004
-
$381.65M(-19.1%)
Dec 2003
$83.15M(+350.8%)
$471.81M(+1.6%)
Sep 2003
-
$464.37M(+47.7%)
Jun 2003
-
$314.30M(-8.0%)
Mar 2003
-
$341.81M(+37.8%)
Dec 2002
$18.45M(+24.3%)
$248.09M(-11.7%)
Sep 2002
-
$281.12M(-4.6%)
Jun 2002
-
$294.60M(-6.1%)
Mar 2002
-
$313.61M(-5.4%)
Dec 2001
$14.84M(+9.4%)
$331.51M(+103.8%)
Sep 2001
-
$162.67M(+9.3%)
Jun 2001
-
$148.84M(-6.3%)
Mar 2001
-
$158.88M(-7.8%)
Dec 2000
$13.56M(-5.9%)
$172.41M(+108.7%)
Sep 2000
-
$82.62M(-0.6%)
Jun 2000
-
$83.10M(-9.7%)
Mar 2000
-
$92.02M(-2.9%)
Dec 1999
$14.40M(-3.4%)
$94.80M(+74.9%)
Sep 1999
-
$54.20M(-4.1%)
Jun 1999
-
$56.50M(-6.5%)
Mar 1999
-
$60.40M(-7.9%)
Dec 1998
$14.90M(-3.9%)
$65.60M(-3.4%)
Sep 1998
-
$67.90M(+2.1%)
Jun 1998
-
$66.50M(-9.0%)
Mar 1998
-
$73.10M(-4.3%)
Dec 1997
$15.50M(+162.7%)
$76.40M(+3.9%)
Sep 1997
-
$73.50M(+1.2%)
Jun 1997
-
$72.60M(-4.8%)
Mar 1997
-
$76.30M(+5.8%)
Dec 1996
$5.90M
$72.10M(+8.7%)
Sep 1996
-
$66.30M(-3.1%)
Jun 1996
-
$68.40M(+186.2%)
Mar 1996
-
$23.90M

FAQ

  • What is Neurocrine Biosciences annual total current assets?
  • What is the all time high annual current assets for Neurocrine Biosciences?
  • What is Neurocrine Biosciences annual current assets year-on-year change?
  • What is Neurocrine Biosciences quarterly total current assets?
  • What is the all time high quarterly current assets for Neurocrine Biosciences?
  • What is Neurocrine Biosciences quarterly current assets year-on-year change?

What is Neurocrine Biosciences annual total current assets?

The current annual current assets of NBIX is $1.72B

What is the all time high annual current assets for Neurocrine Biosciences?

Neurocrine Biosciences all-time high annual total current assets is $1.72B

What is Neurocrine Biosciences annual current assets year-on-year change?

Over the past year, NBIX annual total current assets has changed by +$117.70M (+7.32%)

What is Neurocrine Biosciences quarterly total current assets?

The current quarterly current assets of NBIX is $1.64B

What is the all time high quarterly current assets for Neurocrine Biosciences?

Neurocrine Biosciences all-time high quarterly total current assets is $1.88B

What is Neurocrine Biosciences quarterly current assets year-on-year change?

Over the past year, NBIX quarterly total current assets has changed by -$161.10M (-8.95%)
On this page